All Sauce from Weekly Sauce:

An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds. The oral drug vorasidenib nearly tripled progression-free survival in patients with grade 2 gliomas compared to placebo, nearly 28 months versus 11 months, according to results presented Sunday at the American Society of Clinical Oncology (ASCO)…  read on >  read on >

When people regained weight after obesity surgery, it wasn’t entirely clear what to do next. Now, it appears the weight-loss medications Wegovy and Saxenda can help. Both work by controlling appetite and satiety. Wegovy (semaglutide), however, may be superior to Saxenda (liraglutide), a new study finds. “Our research found that newer anti-obesity medications are effective…  read on >  read on >

There’s a “loneliness epidemic” in the United States, and feelings of isolation have been linked to heart disease, stroke and other health conditions. Now, new research suggests that cancer survivors who feel lonely may be more likely to die than survivors who have more social support. “Loneliness may be linked to worse survival following a…  read on >  read on >

Many men will put off going to the doctor unless they are really sick, but men’s health screenings help catch problems before symptoms appear. So, how can you tell if a health screening or preventive care appointment is right for you? The U.S. National Institutes of Health (NIH), the Centers for Disease Control and Prevention…  read on >  read on >

Summer vacation has begun for some families and screen use may already feel like too much. A psychiatrist from Baylor College of Medicine in Houston offers some tips for making sure smartphones and tablets are put to good use and not used to excess. Dr. Laurel Williams, a professor in the department of psychiatry and…  read on >  read on >

The most common screening test for prostate cancer so often returns a false positive result that it’s no longer recommended for men older than 70, and it’s offered as a personal choice for younger men. But researchers think they’ve found a way to make the blood test for prostate-specific antigen (PSA) accurate enough to significantly…  read on >  read on >